Kleinpenning et al., 2010 - Google Patents
Clinical and histological effects of blue light on normal skinKleinpenning et al., 2010
- Document ID
- 7249466611254820676
- Author
- Kleinpenning M
- Smits T
- Frunt M
- Van Erp P
- Van De Kerkhof P
- Gerritsen R
- Publication year
- Publication venue
- Photodermatology, photoimmunology & photomedicine
External Links
Snippet
Introduction: Phototherapy with visible light is gaining interest in dermatological practice. Theoretically, blue light could induce biological effects comparable to ultraviolet A (UVA) radiation. Objectives: To study the effects of blue light on normal skin in terms of …
- 230000000694 effects 0 title abstract description 19
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kleinpenning et al. | Clinical and histological effects of blue light on normal skin | |
| Narla et al. | Visible light in photodermatology | |
| Vandersee et al. | Blue‐violet light irradiation dose dependently decreases carotenoids in human skin, which indicates the generation of free radicals | |
| Lawrence et al. | The UV/visible radiation boundary region (385–405 nm) damages skin cells and induces “dark” cyclobutane pyrimidine dimers in human skin in vivo | |
| Beigvand et al. | Assessment of laser effects on skin rejuvenation | |
| Randhawa et al. | Visible light induces melanogenesis in human skin through a photoadaptive response | |
| Inoue | 5‐Aminolevulinic acid‐mediated photodynamic therapy for bladder cancer | |
| Kleinpenning et al. | Efficacy of blue light vs. red light in the treatment of psoriasis: a double‐blind, randomized comparative study | |
| Polefka et al. | Effects of solar radiation on the skin | |
| Trevisan et al. | Unusual high exposure to ultraviolet‐C radiation | |
| Mahmoud et al. | Effects of visible light on the skin | |
| Orenstein et al. | Photodynamic therapy of cutaneous lymphoma using 5‐aminolevulinic acid topical application | |
| Jang et al. | A comparative split‐face study of photodynamic therapy with indocyanine green and indole‐3‐acetic acid for the treatment of acne vulgaris | |
| Kohl et al. | Aesthetic effects of topical photodynamic therapy | |
| Falcone et al. | Effects of blue light on inflammation and skin barrier recovery following acute perturbation. Pilot study results in healthy human subjects | |
| Harms et al. | Mitigating Photosensitivity of Erythropoietic Protoporphyria Patients by an Agonistic Analog of α‐Melanocyte Stimulating Hormone | |
| Greaves | The effects of narrowbands of visible light upon some skin disorders: a review | |
| Togsverd‐Bo et al. | Protoporphyrin IX formation and photobleaching in different layers of normal human skin: Methyl‐and hexylaminolevulinate and different light sources | |
| Yoshimoto et al. | Establishment of photoaging in vitro by repetitive UVA irradiation: Induction of characteristic markers of senescence and its prevention by PAPLAL with potent catalase activity | |
| Lehmann | Photodermatoses | |
| Schütz | Blue light and the skin | |
| Steinbauer et al. | Photodynamic therapy in dermatology | |
| Chen et al. | Desferrioxamine enhances 5-aminolaevulinic acid-induced protoporphyrin ix accumulation and therapeutic efficacy for hypertrophic scar | |
| Kosaka et al. | Comparative split‐face study of 5‐aminolevulinic acid photodynamic therapy with intense pulsed light for photorejuvenation of Asian skin | |
| Chikvaidze et al. | ESR study of photoinduced free radicals by visible light in hair and the effects of ascorbic acid (vitamin C) |